Collegium Pharmaceutical Inc (COLL)

Net profit margin

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net income	US$ in thousands	69,190	48,155	-25,002	71,517	26,752
Revenue	US$ in thousands	631,449	566,767	463,933	276,868	310,016
Net profit margin		10.96%	8.50%	-5.39%	25.83%	8.63%

December 31, 2024 calculation

Net profit margin = Net income ÷ Revenue
= $69,190K ÷ $631,449K
= 10.96%

Collegium Pharmaceutical Inc's net profit margin has exhibited fluctuations over the years based on the provided data. The company's net profit margin was 8.63% as of December 31, 2020, reflecting a relatively moderate profitability level. Subsequently, there was a significant increase in profitability, with the net profit margin rising to 25.83% by December 31, 2021, indicating improved efficiency in converting revenue into profit.

However, the trend reversed in the following year, with the net profit margin declining to -5.39% as of December 31, 2022, signaling a period of negative profitability likely due to increased expenses or lower revenue. Collegium Pharmaceutical Inc managed to recover in the subsequent year, with the net profit margin rebounding to 8.50% by December 31, 2023.

As of December 31, 2024, the net profit margin further improved to 10.96%, indicating a positive trend towards higher profitability. Overall, despite some fluctuations, Collegium Pharmaceutical Inc has demonstrated the ability to maintain a reasonable level of profitability over the years, with potential for further growth and efficiency improvements in the future.